INVITRO DRUG SUSCEPTIBILITY AND DOSES OF METRONIDAZOLE REQUIRED FOR CURE IN CASES OF REFRACTORY VAGINAL TRICHOMONIASIS

被引：97

作者：

LOSSICK, JG ^{[1
]}

MULLER, M ^{[1
]}

GORRELL, TE ^{[1
]}

机构：

[1] ROCKEFELLER UNIV,NEW YORK,NY 10021

来源：

关键词：

D O I：

10.1093/infdis/153.5.948

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：948 / 955

页数：8

共 20 条

[1] LACK OF EVIDENCE FOR CANCER DUE TO USE OF METRONIDAZOLE
BEARD, CM
NOLLER, KL
OFALLON, WM
KURLAND, LT
DOCKERTY, MB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (10) : 519 - 522
[2] THE ESTABLISHMENT OF VARIOUS TRICHOMONADS OF ANIMALS AND MAN IN AXENIC CULTURES
DIAMOND, LS
[J]. JOURNAL OF PARASITOLOGY, 1957, 43 (04) : 488 - 490
[3] INACTIVATION OF METRONIDAZOLE BY AEROBIC ORGANISMS
EDWARDS, DI
THOMPSON, EJ
TOMUSANGE, J
SHANSON, D
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1979, 5 (03) : 315 - 316
[4] FORSGREN A, 1979, BRIT J VENER DIS, V55, P351
[5] HEYWORTH R, 1980, LANCET, V2, P476
[6] KANE PO, 1961, BRIT J VENER DIS, V37, P276
[7] KULDA J, 1982, BRIT J VENER DIS, V58, P394
[8] LLOYD D, 1985, J GEN MICROBIOL, V131, P87
[9] LOSSICK JG, 1981, NEW ENGL J MED, V304, P735
[10] LOSSICK JG, 1980, OBSTET GYNECOL, V56, P508